Serum Low C-Peptide Levels Correlate With Low Muscle Mass in Patients With Type 2 Diabetes Mellitus.

The article focuses on exploring the relationship between C-peptide levels and low muscle mass in patients with type 2 diabetes mellitus (T2DM), highlighting the potential of C-peptide as a biomarker for identifying low muscle mass. Topics include the methodology of the study, the prevalence of low muscle mass among patients with varying C-peptide levels, and the association between serum C-peptide levels and low muscle mass after adjusting for potential confounders.